Insider Trading activities of Marinus Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Marinus Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Marinus Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Marinus Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is MRNS. The reporting company's CIK number is 1267813.
The total value of stock buying since 2005 is $19,363,416.
The total value of stock sales since 2005 is $2,362,794.
The total value of stock option exercises since 2005 is $236,728.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Marinus Pharmaceuticals Inc (MRNS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2016-10 0 $0 750,683 $1,042,698 0 $0
2016-08 0 $0 294,737 $442,105 0 $0
2016-07 0 $0 315,879 $593,471 0 $0
2015-09 0 $0 0 $0 39,550 $41,132
2015-07 0 $0 0 $0 56,636 $58,901
2015-06 0 $0 0 $0 3,000 $3,120
2015-04 0 $0 30,000 $284,520 30,000 $31,200
2015-03 0 $0 0 $0 17,608 $18,312
2014-10 0 $0 0 $0 80,830 $84,063
2014-08 2,420,427 $19,363,416 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Marinus Pharmaceuticals Inc insiders (MRNS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2016-10-20 Powell Michael Sale 750,683 1.39 1,042,698
2016-08-08 Canaan Partners Vii Llc (10% Owner) Sale 19,950 1.50 29,925
2016-08-05 Canaan Partners Vii Llc (10% Owner) Sale 129,204 1.50 193,806
2016-08-04 Canaan Partners Vii Llc (10% Owner) Sale 3,329 1.50 4,993
2016-08-03 Canaan Partners Vii Llc (10% Owner) Sale 142,254 1.50 213,381
2016-07-29 Canaan Partners Vii Llc (10% Owner) Sale 24,540 1.71 41,963
2016-07-27 Canaan Partners Vii Llc (10% Owner) Sale 209 1.80 376
2016-07-26 Canaan Partners Vii Llc (10% Owner) Sale 20,380 1.81 36,887
2016-07-25 Canaan Partners Vii Llc (10% Owner) Sale 137,617 1.86 255,967
2016-07-22 Canaan Partners Vii Llc (10% Owner) Sale 133,133 1.94 258,278
2015-09-28 Bloch Stephen M (Director) Option Ex 39,550 1.04 41,132
2015-07-16 Mayleben Timothy M (Director) Option Ex 42,550 1.04 44,252
2015-07-01 Cashman Christopher Michael (President and CEO) Option Ex 14,086 1.04 14,649
2015-06-10 Bloch Stephen M (Director) Option Ex 3,000 1.04 3,120
2015-04-21 Farfel Gail M (Chief Clinical Dev & Reg Offic) Sale 30,000 9.48 284,520
2015-04-21 Farfel Gail M (Chief Clinical Dev & Reg Offic) Option Ex 30,000 1.04 31,200
2015-03-06 Cashman Christopher Michael (PRESIDENT AND CEO) Option Ex 17,608 1.04 18,312
2014-10-08 Cashman Christopher Michael (PRESIDENT AND CEO) Option Ex 80,830 1.04 84,063
2014-08-05 Canaan Partners Vii Llc (Director) Buy 625,000 8.00 5,000,000
2014-08-05 Bloch Stephen M (Director) Buy 625,000 8.00 5,000,000
2014-08-05 Powell Michael (10% Owner) Buy 750,683 8.00 6,005,464
2014-08-05 Vitullo Nicole (Director) Buy 419,744 8.00 3,357,952

Insider trading activities including stock purchases, stock sales, and option exercises of MRNS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Marinus Pharmaceuticals Inc (symbol MRNS, CIK number 1267813) see the Securities and Exchange Commission (SEC) website.